Disclosure profile

Who’s trading KYMR?

Kymera Therapeutics, Inc.

Every disclosed Congress and corporate-insider transaction in KYMR (Kymera Therapeutics, Inc.) — 27 trades from 9 politicians and executives, each AI-scored. Updated as new filings land.

Create a free account to open trades, see the full AI breakdown, and get live alerts when KYMR is traded.

Create a free account →

FilerActionAmountFiledScore

Kymera Therapeutics, Inc. (KYMR) (CIK 0001815442)SEC Form 144Buy$123k2026-06-234

Kymera Therapeutics, Inc. (KYMR) (CIK 0001815442)SEC Form 144Buy$17k2026-06-233

Booth BruceSEC Form 4——2026-06-227

Booth BruceSEC Form 4Sell—2026-06-224

Kymera Therapeutics, Inc. (KYMR) (CIK 0001815442)SEC Form 144Buy—2026-06-226

Kymera Therapeutics, Inc. (KYMR) (CIK 0001815442)SEC Form 144Buy—2026-06-225

Kymera Therapeutics, Inc. (KYMR) (CIK 0001815442)SEC Form 144Buy—2026-06-224

Goodman NoahSEC Form 4——2026-06-225

Kymera Therapeutics, Inc. (KYMR) (CIK 0001815442)SEC Form 144Buy—2026-06-186

Kymera Therapeutics, Inc. (KYMR) (CIK 0001815442)SEC Form 144Buy—2026-06-183

Kymera Therapeutics, Inc. (KYMR) (CIK 0001815442)SEC Form 144Buy—2026-06-176

Kymera Therapeutics, Inc. (KYMR) (CIK 0001815442)SEC Form 144Buy—2026-06-175

Kymera Therapeutics, Inc. (KYMR) (CIK 0001815442)SEC Form 144Buy—2026-06-176

Kymera Therapeutics, Inc. (KYMR)SEC 8-K——2026-06-086

Jacobs Bruce N.SEC Form 4——2026-06-036

Chadwick Jeremy GSEC Form 4Sell—2026-05-274

Kymera Therapeutics, Inc. (KYMR) (CIK 0001815442)SEC Form 144Buy—2026-05-265

Kymera Therapeutics, Inc. (KYMR) (CIK 0001815442)SEC Form 144Buy—2026-05-263

Esposito PamelaSEC Form 4——2026-05-194

Jacobs Bruce N.SEC Form 4——2026-05-196

Ridloff ElenaSEC Form 4——2026-05-114

Kymera Therapeutics, Inc. (KYMR) (CIK 0001815442)SEC Form 144Buy—2026-05-115

Mainolfi NelloSEC Form 4——2026-04-296

Kymera Therapeutics, Inc. (KYMR) (CIK 0001815442)SEC Form 144Buy—2026-04-296

Booth BruceSEC Form 4——2026-04-246

Chadwick Jeremy GSEC Form 4——2026-04-246

Public-record disclosures (SEC Form 4 & Congressional PTRs). Research tool — not investment advice.